Product
rhFSH+rhLH
1 clinical trial
1 indication
Indication
infertilityClinical trial
PErsonalized Addition of Recombinant LH in Suboptimal Responders >35 Years Old (POSEIDON Group 2): A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-08-01